CISPLATIN
Clinical trials for CISPLATIN explained in plain language.
Never miss a new study
Get alerted when new CISPLATIN trials appear
Sign up with your email to follow new studies for CISPLATIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise in bladder cancer trial
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy before and after bladder cancer surgery is safe and effective. About 150 people with muscle-invasive bladder cancer will receive durvalumab plus either ddMVAC or gemcitabine/cisplatin chemo…
Matched conditions: CISPLATIN
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a Steroid-Sparing cocktail tame chemo nausea?
Symptom relief Recruiting nowThis phase 2 trial tests whether a combination of olanzapine and ondansetron can prevent nausea and vomiting caused by high-dose cisplatin chemotherapy in people with solid tumors. The approach aims to reduce steroid use by omitting dexamethasone on days 2 through 4. The study en…
Matched conditions: CISPLATIN
Phase: PHASE2 • Sponsor: Mahidol University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC